Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dauber

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Human Immunology|November 27, 1998
Clinical significance of CMV-specific T helper responses in lung transplant recipientsA Zeevi, P Morel, K Spichty, et al.
Human Immunology|February 13, 2001
Soluble donor HLA class I and beta 2m-free heavy chain in serum of lung transplant recipients: steady-state levels and increases in patients with recurrent CMV infection, acute rejection episodes, and poor outcomeL D DeVito-Haynes, E Jankowska-Gan, K C Meyer, et al.
Transplant Immunology|April 9, 2005
The impact of pharmacogenomic factors on acute persistent rejection in adult lung transplant patientsH X Zheng, A Zeevi, K McCurry, et al.
Transplantation|July 27, 1997
Interleukin 6 and interferon-gamma gene expression in lung transplant recipients with refractory acute cellular rejection: implications for monitoring and inhibition by treatment with aerosolized cyclosporineA Iacono, J Dauber, R Keenan, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Human Immunology|November 27, 1998
Clinical significance of CMV-specific T helper responses in lung transplant recipientsA Zeevi, P Morel, K Spichty, et al.
Human Immunology|February 13, 2001
Soluble donor HLA class I and beta 2m-free heavy chain in serum of lung transplant recipients: steady-state levels and increases in patients with recurrent CMV infection, acute rejection episodes, and poor outcomeL D DeVito-Haynes, E Jankowska-Gan, K C Meyer, et al.
Transplant Immunology|April 9, 2005
The impact of pharmacogenomic factors on acute persistent rejection in adult lung transplant patientsH X Zheng, A Zeevi, K McCurry, et al.
Transplantation|July 27, 1997
Interleukin 6 and interferon-gamma gene expression in lung transplant recipients with refractory acute cellular rejection: implications for monitoring and inhibition by treatment with aerosolized cyclosporineA Iacono, J Dauber, R Keenan, et al.
Pageof 2